The mechanisms of mucus hypersecretion in COPD are poorly understood, even though sputum production is associated with an accelerated rate of decline in FEV1 and with increased mortality from COPD. In addition, the reasons why only a minority of cigarette smokers develop COPD is unknown. To date, clinical research in COPD has been significantly hampered by problems in measuring outcome indicators related to mucus hypersecretion. We hypothesize that smokers with COPD have a T cell phenotype characterized by predominance of CD4+ T cells of the subtype which contributes to overexpression of mucin genes, increased numbers of goblet cells, and increased levels of both stored and secreted mucin. In addition, we hypothesize that the airway phenotype in smokers without COPD will not be normal but will be intermediate to that observed in healthy subjects and smokers with COPD. Finally, we hypothesize that treatment of smokers with COPD with inhaled corticosteroids will decrease lymphocytic inflammation, mucin gene expression, and the levels of stored and secreted mucin. We propose to test our hypotheses in three groups of human subjects smokers with COPD, smokers without COPD and healthy non smoking controls. We will apply methods recently developed in our laboratory for measuring mucin gene expression, goblet cell hyperplasia and secreted mucin levels as well as methods we have adopted from others for purifying and phenotyping airway T cells.
Aim 1 will determine the phenotype of the airway mucosa in smokers with COPD compared to smokers without COPD and non smoking controls with emphasis on the numbers and subtypes of T lymphocytes, the numbers of goblet cells, and the relationship between stored and secreted mucin glycoproteins.
Aim 2 will determine which of the nine currently identified mucin genes are overexpressed in smokers with and without COPD.
Aim 3 will determine in inhaled corticosteroid treatment in smokers with COPD is associated with a reduction in lymphocyte number, mucin gene expression, goblet cell number, or in the levels of stored and secreted mucin. The proposed studies address an unmet need, because no clinical studies have been published focusing on T cell subtypes, mucin genes, and goblet cells in human COPD. The application of the methods described here provide the opportunity to begin to understand the relationship between lymphocytic inflammation and mucin gene expression in COPD, and may suggest strategies for improving treatment.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL066564-04
Application #
6779062
Study Section
Special Emphasis Panel (ZHL1-CSR-H (S2))
Program Officer
Croxton, Thomas
Project Start
2001-08-01
Project End
2005-07-31
Budget Start
2004-08-01
Budget End
2005-07-31
Support Year
4
Fiscal Year
2004
Total Cost
$331,875
Indirect Cost
Name
University of California San Francisco
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Jia, Guiquan; Erickson, Richard W; Choy, David F et al. (2012) Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients. J Allergy Clin Immunol 130:647-654.e10
Choy, David F; Modrek, Barmak; Abbas, Alexander R et al. (2011) Gene expression patterns of Th2 inflammation and intercellular communication in asthmatic airways. J Immunol 186:1861-9
Woodruff, Prescott G; Modrek, Barmak; Choy, David F et al. (2009) T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med 180:388-95
Woodruff, Prescott G; Boushey, Homer A; Dolganov, Gregory M et al. (2007) Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids. Proc Natl Acad Sci U S A 104:15858-63
Innes, Anh L; Woodruff, Prescott G; Ferrando, Ronald E et al. (2006) Epithelial mucin stores are increased in the large airways of smokers with airflow obstruction. Chest 130:1102-8
Shi, Guo-Ping; Dolganov, Gregory M (2006) Comprehensive transcriptome of proteases and protease inhibitors in vascular cells. Stroke 37:537-41
Woodruff, Prescott G; Koth, Laura L; Yang, Yee Hwa et al. (2005) A distinctive alveolar macrophage activation state induced by cigarette smoking. Am J Respir Crit Care Med 172:1383-92
Baumgarth, Nicole; Szubin, Richard; Dolganov, Greg M et al. (2004) Highly tissue substructure-specific effects of human papilloma virus in mucosa of HIV-infected patients revealed by laser-dissection microscopy-assisted gene expression profiling. Am J Pathol 165:707-18